Stangier J[au] - Search Results

Year	Number of Results
1986	1
1987	1
1988	1
1992	2
1999	1
2000	9
2001	2
2002	1
2004	1
2005	2
2006	1
2007	4
2008	4
2009	2
2010	3
2011	2
2012	5
2013	1
2015	5
2016	5
2017	6
2018	1
2019	1
2024	0

1

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI. Pollack CV Jr, et al. Among authors: stangier j. N Engl J Med. 2017 Aug 3;377(5):431-441. doi: 10.1056/NEJMoa1707278. Epub 2017 Jul 11. N Engl J Med. 2017. PMID: 28693366 Free article. Clinical Trial.

2

Idarucizumab for Dabigatran Reversal.

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI. Pollack CV Jr, et al. Among authors: stangier j. N Engl J Med. 2015 Aug 6;373(6):511-20. doi: 10.1056/NEJMoa1502000. Epub 2015 Jun 22. N Engl J Med. 2015. PMID: 26095746 Free article. Clinical Trial.

3

Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin.

Eisert WG, Hauel N, Stangier J, Wienen W, Clemens A, van Ryn J. Eisert WG, et al. Among authors: stangier j. Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1885-9. doi: 10.1161/ATVBAHA.110.203604. Epub 2010 Jul 29. Arterioscler Thromb Vasc Biol. 2010. PMID: 20671233 Review.

4

Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.

Stangier J, Clemens A. Stangier J, et al. Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:9S-16S. doi: 10.1177/1076029609343004. Epub 2009 Aug 19. Clin Appl Thromb Hemost. 2009. PMID: 19696042 Free article. Review.

5

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.

Stangier J. Stangier J. Clin Pharmacokinet. 2008;47(5):285-95. doi: 10.2165/00003088-200847050-00001. Clin Pharmacokinet. 2008. PMID: 18399711 Review.

6

Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.

Reilly PA, van Ryn J, Grottke O, Glund S, Stangier J. Reilly PA, et al. Among authors: stangier j. Am J Med. 2016 Nov;129(11S):S64-S72. doi: 10.1016/j.amjmed.2016.06.007. Epub 2016 Aug 26. Am J Med. 2016. PMID: 27569674 Free article. Review.

7

Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects.

Reilly PA, van Ryn J, Grottke O, Glund S, Stangier J. Reilly PA, et al. Among authors: stangier j. Am J Emerg Med. 2016 Nov;34(11S):26-32. doi: 10.1016/j.ajem.2016.09.050. Epub 2016 Sep 28. Am J Emerg Med. 2016. PMID: 27707528 Free article. Review.

8

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.

van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A. van Ryn J, et al. Among authors: stangier j. Thromb Haemost. 2010 Jun;103(6):1116-27. doi: 10.1160/TH09-11-0758. Epub 2010 Mar 29. Thromb Haemost. 2010. PMID: 20352166 Review.

9

Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran.

Glund S, Coble K, Gansser D, Stangier J, Hoermann K, Pollack CV, Reilly P. Glund S, et al. Among authors: stangier j. J Thromb Haemost. 2019 Aug;17(8):1319-1328. doi: 10.1111/jth.14476. Epub 2019 Jun 18. J Thromb Haemost. 2019. PMID: 31050868 Free PMC article. Clinical Trial.

10

Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.

Norris S, Ramael S, Ikushima I, Haazen W, Harada A, Moschetti V, Imazu S, Reilly PA, Lang B, Stangier J, Glund S. Norris S, et al. Among authors: stangier j. Br J Clin Pharmacol. 2017 Aug;83(8):1815-1825. doi: 10.1111/bcp.13269. Epub 2017 Apr 6. Br J Clin Pharmacol. 2017. PMID: 28230262 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year